These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 15838486

  • 21. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
    Ge JJ, Zhao ZW, Zhou ZC, Wu S, Zhang R, Pan FM, Abendroth DK.
    Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
    [Abstract] [Full Text] [Related]

  • 22. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
    Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG, Lowenstein PR, Heagerty AM.
    Circulation; 2003 Dec 02; 108(22):2819-25. PubMed ID: 14638551
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia.
    Kibbe MR, Tzeng E, Gleixner SL, Watkins SC, Kovesdi I, Lizonova A, Makaroun MS, Billiar TR, Rhee RY.
    J Vasc Surg; 2001 Jul 02; 34(1):156-65. PubMed ID: 11436090
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D, de Vries MR, Grimbergen JM, Karper JC, van Bockel JH, Quax PH.
    J Vasc Surg; 2010 Feb 02; 51(2):429-37. PubMed ID: 20036101
    [Abstract] [Full Text] [Related]

  • 28. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M, Lahme B, Van de Leur E, Gressner AM, Weiskirchen R.
    Cell Growth Differ; 2002 Jun 02; 13(6):265-73. PubMed ID: 12114216
    [Abstract] [Full Text] [Related]

  • 29. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA, Jiang Z, Klingman NV, Pfahnl CL, Abouhamze ZS, Frase CD, Schultz GS, Ozaki CK.
    J Vasc Surg; 2004 May 02; 39(5):1084-90. PubMed ID: 15111865
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Expression of bone morphogenic protein 2/4, transforming growth factor-beta1, and bone matrix protein expression in healing area between vascular tibia grafts and irradiated bone-experimental model of osteonecrosis.
    Schultze-Mosgau S, Lehner B, Rödel F, Wehrhan F, Amann K, Kopp J, Thorwarth M, Nkenke E, Grabenbauer G.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1189-96. PubMed ID: 15752901
    [Abstract] [Full Text] [Related]

  • 33. Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff.
    Matsumoto T, Komori K, Yonemitsu Y, Morishita R, Sueishi K, Kaneda Y, Sugimachi K.
    J Vasc Surg; 1998 Jan 15; 27(1):135-44. PubMed ID: 9474091
    [Abstract] [Full Text] [Related]

  • 34. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model.
    Rotmans JI, Velema E, Verhagen HJ, Blankensteijn JD, de Kleijn DP, Stroes ES, Pasterkamp G.
    J Vasc Surg; 2004 Feb 15; 39(2):432-9. PubMed ID: 14743149
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice.
    Eefting D, Bot I, de Vries MR, Schepers A, van Bockel JH, Van Berkel TJ, Biessen EA, Quax PH.
    J Vasc Surg; 2009 Jul 15; 50(1):152-60. PubMed ID: 19563963
    [Abstract] [Full Text] [Related]

  • 37. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model.
    Faries PL, Marin ML, Veith FJ, Ramirez JA, Suggs WD, Parsons RE, Sanchez LA, Lyon RT.
    J Vasc Surg; 1996 Sep 15; 24(3):463-71. PubMed ID: 8808969
    [Abstract] [Full Text] [Related]

  • 38. The temporal expression of transforming growth factor-beta 1 in early aortocoronary vein grafts.
    Dattilo JB, Lust RM, Dattilo MP, Parker FM, Meadows WM, Sun YS, Chitwood WR, Makhoul RG.
    J Surg Res; 1997 May 15; 69(2):349-53. PubMed ID: 9224405
    [Abstract] [Full Text] [Related]

  • 39. [Mechanism of intimal hyperplasia of venous grafts after coronary artery bypass grafting, an experimental study].
    Xiao M, You W, Yuan Z, Xu G.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1550-2. PubMed ID: 12609065
    [Abstract] [Full Text] [Related]

  • 40. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
    Petrofski JA, Hata JA, Gehrig TR, Hanish SI, Williams ML, Thompson RB, Parsa CJ, Koch WJ, Milano CA.
    J Thorac Cardiovasc Surg; 2004 Jan 25; 127(1):27-33. PubMed ID: 14752409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.